Sanjay Rao, MD
Medical Director, Lakeside Eye Clinic
Member of the Healthcare Council
Council Member Biography
Sanjay Rao, MD, is the Medical Director and Director of Cornea and Refractive Surgery at the Lakeside Eye Clinic in Chicago. He was previously the Director of Cornea and Refractive Surgery at the University of Chicago. He has clinical expertise in diseases of the cornea and is a high volume cataract, LASIK, and corneal transplant surgeon. Dr. Rao works extensively with many new refractive technologies and presbyopia treatments including accommodative and multifocal intraocular lenses, custom ablation/wavefront LASIK, conductive keratoplasty, femtosecond lasers, and corneal inlays. He also heads the research division at Lakeside Eye Clinic which focuses on new refractive technologies, herpes keratitis, dry eye treatments, novel pharmaceuticals, and ocular pharmaceutical delivery systems. Dr. Rao serves as a principal investigator for several industry-sponsored clinical trials and as a scientific advisory board member for several pharmaceutical and device companies. (This is me - Update Profile)
Employment History
- 2007 - present
- Medical Director, Lakeside Eye Clinic
- 2005 - 2007
- Director of Cornea and Refractive Surgery, CHICAGO EYE INSTITUTE
- 2003 - 2005
- Director of Cornea and Refractive Surgery, THE UNIVERSITY OF CHICAGO MEDICAL CENTER
GLG NewsSM Analyses by Sanjay Rao, MD(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Impact of the Avastin/Lucentis controversy on the rest of ophthalmology
March 28, 2007
Sanjay Rao, MD, Medical Director, Lakeside Eye Clinic
Retinal specialist on the Avastin/Lucentis Controversy | patentdocs.typepad.com
This article describes the perspective of a retinal specialist on the Avastin/Lucentis controversy. In mid-February the National Institutes of Health announced that it would conduct a head to head trial comparing the effectiveness of Lucentis and Avastin for the treatment of wet age...
-
Multifocal contact lenses unlikely to impact market for surgical correction
March 21, 2007
Sanjay Rao, MD, Medical Director, Lakeside Eye Clinic
Better Vision Without Looking Your Age | www.nytimes.com
This New York Times article describes many of the vision correction options available to individuals with presbyopia. Because of the growing population of baby boomers, there is significant public interest in options that allow individuals freedom from reading glasses. Multifocal contact...
-
Alcon's Aqualase System: A safer approach to cataract surgery?
March 21, 2007
Sanjay Rao, MD, Medical Director, Lakeside Eye Clinic
AquaLase shows trend toward less foveal thickening in diabetic patients | www.osnsupersite.com
This article presents the results of a study comparing standard phacoemulsification to Aqualase. Complication rates were similar between the two procedures. The 63 patient study looked in particular at foveal thickening after surgery. While no statistical significance was demonstrated,...
-
Corneal inlays: Another entrant into the presbyopia treatment wars
March 9, 2007
Sanjay Rao, MD, Medical Director, Lakeside Eye Clinic
Corneal inlay is versatile approach for presbyopia | www.ophthalmologytimes.com
The early results of a new corneal inlay (PresbyLens, ReVision Optics) are presented. A corneal inlay is placed underneath a LASIK corneal flap in the non-dominant eye to correct presbyopia. This version of a corneal inlay is 1.5mm in diameter. The outcomes of 15 patients showed good...
Leading institutions connect with Sanjay Rao, MD through GLG
GLG Study Groups with Sanjay Rao, MD(?)
| Study Group Name | No. Members |
|---|---|
| Juvederm Users: Cosmetic Dermatologists (US) | 134 |
| LASIK Surgeons (US) | 140 |
| Ophthalmologists (US) | 1138 |
| Physicians who Implant Intraocular Lenses | 217 |
GLG Live Meetings with Sanjay Rao, MD(?)
Recent Seminars
-
November 20, 2006 | San Francisco
GLGi: Intraocular Lenses (IOLs) -
May 9, 2006 | Chicago
GLGi: Ophthalmology